Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.

RPEP-070592023Kosiborod, Mikhail N; Abildstrøm, Steen Z; Borlaug, Barry A; Butler, Javed; Rasmussen, Søren; Davies, Melanie; Hovingh, G Kees; Kitzman, Dalane W; Lindegaard, Marie L; Møller, Daniél V; Shah, Sanjiv J; Treppendahl, Marianne B; Verma, Subodh; Abhayaratna, Walter; Ahmed, Fozia Z; Chopra, Vijay; Ezekowitz, Justin; Fu, Michael; Ito, Hiroshi; Lelonek, Małgorzata; Melenovsky, Vojtech; Merkely, Bela; Núñez, Julio; Perna, Eduardo; Schou, Morten; Senni, Michele; Sharma, Kavita; Van der Meer, Peter; von Lewinski, Dirk; Wolf, Dennis; Petrie, Mark C

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.

The New England journal of medicine, 389(12), 1069-1084

View on PubMed ↗Publisher’s paper ↗

Citation

Kosiborod, Mikhail N; Abildstrøm, Steen Z; Borlaug, Barry A; Butler, Javed; Rasmussen, Søren; Davies, Melanie; Hovingh, G Kees; Kitzman, Dalane W; Lindegaard, Marie L; Møller, Daniél V; Shah, Sanjiv J; Treppendahl, Marianne B; Verma, Subodh; Abhayaratna, Walter; Ahmed, Fozia Z; Chopra, Vijay; Ezekowitz, Justin; Fu, Michael; Ito, Hiroshi; Lelonek, Małgorzata; Melenovsky, Vojtech; Merkely, Bela; Núñez, Julio; Perna, Eduardo; Schou, Morten; Senni, Michele; Sharma, Kavita; Van der Meer, Peter; von Lewinski, Dirk; Wolf, Dennis; Petrie, Mark C. (2023). Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.. The New England journal of medicine, 389(12), 1069-1084. https://doi.org/10.1056/NEJMoa2306963